Call MEDISCA now at 1-800-932-10391300 786 392

Essential Elements of Personalised

Analgesic Medications


Analgesic therapies present particular issues and challenges to the physicians and pharmacists. The practice-based activity will provide general practitioners and pharmacists with the opportunity to enhance their competency as it relates to the many therapeutic options used in analgesic therapies. Having been presented with a prescription indicating a need for a medication, the participants will use uniquely designed patient assessment tools, select appropriate delivery systems for the specific analgesics and nutritional supplements prescribed, and then monitor patient progress.

During this process the participants will have learned how to relate drug mechanisms of action to physiological and pathophysiological pathways responsible for the elicitation of a pain response, how to conduct a patient needs analysis and then work collaboratively to provide expertise with respect to the therapeutic, concomitant adjuvant, and lifestyle and behavior modification options available to the physician.

Finally, participants will apply monitoring tools and strategies to maintain patient compliance with prescribed analgesic initiatives. Case work will be documented and clinical findings recorded in a formal manner for purposes of confidential communication, record keeping and statistical analysis.


General practitioners and pharmacists engaged in prescription analgesic therapies.


  • Predisposing activity.
  • A live event with casework.
  • Reinforcing activity (physicians only).


  1. Review the basic structure and function of the nervous system
  2. Relate physiological and biochemical features of signal transmission and transduction of nerve impulses
  3. Describe the anatomy and physiology of the pathways involved in nociceptive and neurogenic pain
  4. Explain the mechanisms of peripheral and central sensitization and how they relate to acute and chronic pain
  5. Describe the contributing factors to pathophysiological pathways including cognitive mechanisms, nociceptive responses, wind-up, and central sensitization
  6. Identify pharmacological targets for the treatment of pain.


  1. Employ customised principles and techniques of analgesic formulation-related delivery systems.
  2. Identify and develop novel targeting approaches to physiological and pathophysiological pathways.
  3. Relate physiological and biochemical features of signal transmission and transduction.
  4. Interpret deleterious signal elicitation and subsequent excitation, inhibition, cessation and modulation though analgesic therapy.
  5. Assess the various routes of delivery, delivery systems, dosage forms and dispensing mechanisms used in analgesic therapy, adjunct therapy, supplementation and specific aspects of lifestyle management.
  6. Evaluate and select therapeutic alternatives for specific classifications related to analgesic therapy; specifically formulations which may be prescribed or used by the physician in the treatment of nociception, neuropathology, neuromas, centralisation, direct and indirect consequences of vascular deprivation, neural budding and plasticity.
  7. Review comprehensive patient assessment chart data; includes prior medical history, familial history, differential diagnoses, lifestyle behaviors, signs and symptoms, laboratory test results, and analgesic-related medication, adjunct pharmacotherapeutic and supplementation treatments. Interpret and apply this resource.



Senior Associate, Gates Healthcare Associates.
Dr. Ken Speidel is known for his experience in pharmacy practice and education, including his international recognition as a pharmacotherapeutic specialist in endocrinology and pain management, as well as his expertise in sterile and non-sterile compounding processes. Dr. Speidel is a retired Professor of Pharmacy from the University of Findlay (United States) and has assisted in the development and facilitation of various ACPE-accredited educational programs. Dr. Speidel was an advisor for the development of the Pharmacy Compounding Accreditation Board (PCAB) and remains a surveyor and accreditation expert for PCAB/ACHC.


Integrative Medicine Physician, Beach Street Centre, Merimbula

Lily Thomas is an Integrative Medical Doctor practicing on the Sapphire Coast in NSW, Australia with over 20 years’ experience in treating all aspects of Health. Thomas is a Fellow of the Australasian College of Nutrition and Environmental Medicine (ACNEM) and Past President of the Australian Integrative Medical Association (AIMA). Tomas was the founding Editor of Advances in Integrative Medicine, Elsevier. Thomas has also had the pleasure of lecturing at many renowned organizations and associations, including AIMA, ACNEM, Australasian Academy of Anti-Aging Medicine (A5M), Australian Lifestyle Medicine Association (ALMA), BioBalance Health Australia, MINDD Foundation, Australian Acupuncture & Chinese Medicine Association (AACMA), University of Western Sydney- Medicine Faculty, Royal Australian College of General Practitioners (RACGP), and the McGrath Foundation- Breast Cancer.

Other Facilitators may also be involved in the presentation of the Training Activity.


Accreditation Pending.


Activity material is Copyright© 2008-2019 LP3 Network Inc.


Full attendance and the completion of an activity evaluation and practical skill set competency evaluation are a compulsory requirement to achieve credit for the live event.


It is a requirement of the Australian Pharmacy Council Accreditation Standards for Continuing Professional Development Activities that full disclosure of conflicts of interest be made available to participants. This activity is independent of any known bias, prejudice or commercial interest. Both MEDISCA Australia and LP3 Network Inc. assist with the marketing of this activity. LP3 Network Inc. is an independent corporation. LP3 Network Inc. has an established agreement with MEDISCA Australia ensuring that it has no influence on LP3 Network Inc. as it relates to activity offerings.


This learning activity has received financial support from MEDISCA Inc. in the form of an educational grant.


Special rates for hotel accommodations have been arranged for activity participants. Payment for hotel accommodations is at the expense of the activity participant.


As a matter of activity programming, meals and refreshments during live activities have been provided by MEDISCA Australia.


In the event that MEDISCA Australia cancels a course, MEDISCA Australia’s sole liability shall be course repayment. In no event shall MEDISCA Australia be responsible for any costs arising from such cancellation, including but not limited to travel and/or accommodation.
In the event a Registrant cancels their enrollment in a CPD Activity, a written request must be sent to MEDISCA Australia requesting ‘Cancellation without Transfer’ to an alternate live CPD Activity event date. If cancellation occurs at greater than or equal to 31 days from live activity event date, then registrant will receive a 75% refund; 15-30 days a 50% refund; and less than or equal to 14 days no refund. MEDISCA Australia shall be excused from any delay caused by reason of any occurrence or contingency beyond its reasonable control (a “Force Majeure”), including but not limited to, acts of God, hurricane, earthquake, labour disputes, strikes, riots, war, and governmental requirements. The obligation to pay money to MEDISCA Australia in a timely manner is absolute and shall not be subject to this Force Majeure provision. In such event, MEDISCA Australia will not issue any refunds, only transfer to an alternate live activity event date. This cancellation and refund policy is specific to courses offered in Australia. To obtain information on the cancellation and refund policy for courses offered outside of Australia, please speak to a MEDISCA Australia representative or refer to your course-specific registration page.


This transfer policy is only applicable to courses that are offered in Australia. Transfer policy is only in effect if requested greater than or equal to 14 days prior to the original live activity event date. Failure to submit “Transfer Request” at least 14 days prior to original live activity event date will default to “Cancellation and Refund Policy”. Transfer policy can only apply one (1) time. Transfer to a new live event date must be within current calendar year. Failure to attend the new live activity event will lead to no refund and will no longer be transferable. Confirmation of new activity date is subject to the approval by MEDISCA Australia based on the number of available seats within the selected live activity event.


We have placed cookies on your device to help make this website better.

We also use cookies to collect information for making reports and to help us improve the site. The cookies collect information in an anonymous form.

Copyright® 1989-2021 Medisca Inc.
All rights reserved

MEDISCA is ISO 9001:2008 certified